StockData

Aspen Neuroscience, Inc. (ASPE) stock

ASPENasdaqPharmaceutical PreparationsFiscal year ends December 31
$13.61−0.21 (-1.52%)

Close on Nov 12, 2026Market cap –P/E –Yield –

Key statistics

Valuation at the latest close; fundamentals over fiscal

Valuation

Market cap
–
P/E ratio
–
Price to sales
–
Price to book
–
Dividend yield
–
Free cash flow yield
–

Trading

Previous close
$13.82
Open
$13.82
Day's range
$12.62 – $14.42
Volume
267,365
Average volume (20 days)
233,346

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.

PeriodASPES&P 500DifferenceASPE per yearS&P 500 per year
1 month+136000.0%-2.7%+136002.7 pts
3 months+136000.0%-1.7%+136001.7 pts
Year to date+136000.0%+11.9%+135988.1 pts
1 year+136000.0%+12.0%+135988.0 pts
3 years+136000.0%+78.2%+135921.8 pts+1008.2%+21.2%
5 years+136000.0%+73.2%+135926.8 pts+323.4%+11.6%
10 years+136000.0%+309.6%+135690.4 pts+105.8%+15.1%

Aspen Neuroscience stock: common questions

What is Aspen Neuroscience's stock price?

ASPE closed at $13.61 on Nov 12, 2026, down 1.52% on the day.

Does Aspen Neuroscience pay a dividend?

No. Aspen Neuroscience has not paid a cash dividend over the last twelve months.

How has ASPE stock performed over the past year?

Including dividends, ASPE returned +136000.0% over the past year, against +12.0% for the S&P 500.

Who are Aspen Neuroscience's competitors?

Companies most similar to Aspen Neuroscience by business, industry and size include LLY, JNJ, ABBV, MRK, AZN.

See a number that looks wrong?